{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:07:04Z","timestamp":1793210824740,"version":"4.5.0"},"reference-count":60,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:00:00Z","timestamp":1700784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Sciences"],"abstract":"<jats:p>The clinical category of immune-mediated cerebellar ataxias (IMCAs) has been established after 3 decades of clinical and experimental research. The cerebellum is particularly enriched in antigens (ion channels and related proteins, synaptic adhesion\/organizing proteins, transmitter receptors, glial cells) and is vulnerable to immune attacks. IMCAs include various disorders, including gluten ataxia (GA), post-infectious cerebellitis (PIC), Miller Fisher syndrome (MFS), paraneoplastic cerebellar degeneration (PCD), opsoclonus myoclonus syndrome (OMS), and anti-GAD ataxia. Other disorders such as multiple sclerosis (MS), acute disseminated encephalomyelitis (ADEM), Beh\u00e7et disease, and collagen vascular disorders may also present with cerebellar symptoms when lesions are localized to cerebellar pathways. The triggers of autoimmunity are established in GA (gluten sensitivity), PIC and MFS (infections), PCD (malignancy), and OMS (infections or malignant tumors). Patients whose clinical profiles do not match those of classic types of IMCAs are now included in the spectrum of primary autoimmune cerebellar ataxia (PACA). Recent remarkable progress has clarified various characteristics of these etiologies and therapeutic strategies in terms of immunotherapies. However, it still remains to be elucidated as to how immune tolerance is broken, leading to autoimmune insults of the cerebellum, and the consecutive sequence of events occurring during cerebellar damage caused by antibody- or cell-mediated mechanisms. Antibodies may specifically target the cerebellar circuitry and impair synaptic mechanisms (synaptopathies). The present Special Issue aims to illuminate what is solved and what is unsolved in clinical practice and the pathophysiology of IMCAs. Immune ataxias now represent a genuine category of immune insults to the central nervous system (CNS).<\/jats:p>","DOI":"10.3390\/brainsci13121626","type":"journal-article","created":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T03:43:59Z","timestamp":1700797439000},"page":"1626","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Recent Advances in Immune-Mediated Cerebellar Ataxias: Pathogenesis, Diagnostic Approaches, Therapies, and Future Challenges\u2014Editorial"],"prefix":"10.3390","volume":"13","author":[{"given":"Mario","family":"Manto","sequence":"first","affiliation":[{"name":"Service de Neurologie, M\u00e9diath\u00e8que Jean Jacquy, CHU-Charleroi, 6000 Charleroi, Belgium"},{"name":"Service des Neurosciences, Universit\u00e9 de Mons, 7000 Mons, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0513-1811","authenticated-orcid":false,"given":"Hiroshi","family":"Mitoma","sequence":"additional","affiliation":[{"name":"Department of Medical Education, Tokyo Medical University, Tokyo 160-8402, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,11,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Manto, M., Gruol, D.L., Schmahmann, J.D., Koibuchi, N., and Sillitoe, R.V. (2022). Handbook of Cerebellum and Cerebellar Disorders, Springer. Available online: https:\/\/link.springer.com\/referencework\/10.1007\/978-3-030-23810-0.","DOI":"10.1007\/978-3-030-23810-0"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Wahab, D.Y.A.A., Gau, C.H., Zakaria, R., Karuppan, M.K.M., A-Rahbi, B.S., Abdullah, Z., Alrafiah, A., Abdullah, J.M., and Muthuraju, S. (2019). Review on cross talk between neurotransmitters and neuroinflammation in striatum and cerebellum in the mediation of motor behaviour. Biomed. Res. Int., 2019.","DOI":"10.1155\/2019\/1767203"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.neurol.2010.07.032","article-title":"Clinical presentation of immune-mediated cerebellar ataxia","volume":"167","author":"Demarquay","year":"2011","journal-title":"Rev. Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/B978-0-444-64189-2.00021-4","article-title":"Immune-mediated ataxias","volume":"155","author":"Joubert","year":"2018","journal-title":"Handb. Clin. Neurol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11940-017-0485-y","article-title":"Treatment of cerebellar ataxia in the context of systemic diseases","volume":"19","author":"Proudfoot","year":"2017","journal-title":"Curr. Treat. Options Neurol."},{"key":"ref_6","first-page":"512","article-title":"Miller Fisher\u2019s syndrome","volume":"32","author":"Teener","year":"2012","journal-title":"Semin. Neurol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"957361","DOI":"10.3389\/fimmu.2022.957361","article-title":"Serological biomarkers in autoimmune GFAP astrocytopathy","volume":"13","author":"Fu","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jneuroim.2019.04.004","article-title":"Clinical characteristics of autoimmune GFAP astrocytopathy","volume":"332","author":"Kimura","year":"2019","journal-title":"J. Neuroimmunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/WCO.0000000000000676","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy","volume":"32","author":"Kunchok","year":"2019","journal-title":"Curr. Opin. Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Kimura, A., Takekoshi, A., and Shimohata, T. (2022). Characteristics of Movement Disorders in Patients with Autoimmune GFAP Astrocytopathy. Brain Sci., 12.","DOI":"10.3390\/brainsci12040462"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1001\/jamaneurol.2016.2549","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy: A novel meningoencephalomyelitis","volume":"73","author":"Fang","year":"2016","journal-title":"JAMA Neurol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s12311-020-01132-8","article-title":"Diagnostic Criteria for Primary Autoimmune Cerebellar Ataxia-Guidelines from an International Task Force on Immune-Mediated Cerebellar Ataxias","volume":"19","author":"Hadjivassiliou","year":"2020","journal-title":"Cerebellum"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Hadjivassiliou, M., Manto, M., and Mitoma, H. (2022). Rare Etiologies in Immune-Mediated Cerebellar Ataxias: Diagnostic Challenges. Brain Sci., 12.","DOI":"10.3390\/brainsci12091165"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1111\/ene.14659","article-title":"Treatment-responsive primary autoimmune cerebellar ataxia in a patient with IgG and IgM anticerebellar antibodies","volume":"28","author":"Jaffe","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Alam Parvez, S., and Ohtsuki, G. (2022). Acute Cerebellar Inflammation and Related Ataxia: Mechanisms and Pathophysiology. Brain Sci., 12.","DOI":"10.3390\/brainsci12030367"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuron.2015.11.024","article-title":"Discovery of Novel Blood-Brain Barrier Targets to Enhance Brain Uptake of Therapeutic Antibodies","volume":"89","author":"Zuchero","year":"2016","journal-title":"Neuron"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.tips.2019.11.001","article-title":"Overcoming the Brain Barriers: From Immune Cells to Nanoparticles","volume":"41","author":"Charabati","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00401-018-1815-1","article-title":"Functional morphology of the blood-brain barrier in health and disease","volume":"135","author":"Liebner","year":"2018","journal-title":"Acta Neuropathol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Hampe, C.S., and Mitoma, H. (2022). A Breakdown of Immune Tolerance in the Cerebellum. Brain Sci., 12.","DOI":"10.3390\/brainsci12030328"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"20417314221095997","DOI":"10.1177\/20417314221095997","article-title":"Modeling the blood-brain barrier for treatment of central nervous system (CNS) diseases","volume":"13","author":"Rice","year":"2022","journal-title":"J. Tissue Eng."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Clark, H.B. (2022). The neuropathology of autoimmune ataxias. Brain Sci., 12.","DOI":"10.3390\/brainsci12020257"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/B978-0-444-63956-1.00008-4","article-title":"The neuropathology of the adult cerebellum","volume":"154","author":"Koeppen","year":"2018","journal-title":"Handb. Clin. Neurol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Loehrer, P.A., Zieger, L., and Simon, O.J. (2021). Update on Paraneoplastic Cerebellar Degeneration. Brain Sci., 11.","DOI":"10.3390\/brainsci11111414"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/B978-0-444-51892-7.00013-9","article-title":"Paraneoplastic cerebellar degeneration","volume":"103","author":"Vernino","year":"2012","journal-title":"Handb. Clin. Neurol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1002\/1097-0142(19911015)68:8<1835::AID-CNCR2820680833>3.0.CO;2-N","article-title":"Breast cancer and paraneoplastic cerebellar degeneration","volume":"68","author":"Waterhouse","year":"1991","journal-title":"Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e200006","DOI":"10.1212\/NXI.0000000000200006","article-title":"Paraneoplastic Cerebellar Degeneration With P\/Q-VGCC vs Yo Autoantibodies","volume":"9","author":"Winklehner","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00381-016-3284-y","article-title":"Hodgkin\u2019s lymphoma associated with paraneoplastic cerebellar degeneration in children: A case report and review of the literature","volume":"33","author":"Gungor","year":"2017","journal-title":"Childs Nerv. Syst."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Mendes, N.T., Ronchi, N.R., and Silva, G.D. (2022). A Systematic Review on Anti-Yo\/PCA-1 Antibody: Beyond Cerebellar Ataxia in Middle-Aged Women with Gynecologic Cancer. Cerebellum.","DOI":"10.1007\/s12311-022-01492-3"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12974-014-0160-0","article-title":"Neuronal uptake of anti-Hu antibody, but not anti-Ri antibody, leads to cell death in brain slice cultures","volume":"11","author":"Greenlee","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s12311-021-01346-4","article-title":"Anti-Tr\/DNER Antibody-Associated Cerebellar Ataxia: A Systematic Review","volume":"21","author":"Campana","year":"2022","journal-title":"Cerebellum"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jocn.2014.06.103","article-title":"Anti-Ri-associated paraneoplastic brainstem cerebellar syndrome with coexisting limbic encephalitis in a patient with mixed large cell neuroendocrine lung carcinoma","volume":"22","author":"Mitchell","year":"2015","journal-title":"J. Clin. Neurosci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1055\/s-0039-3402739","article-title":"Acute Vestibular Syndrome","volume":"40","author":"Kerber","year":"2020","journal-title":"Semin. Neurol."},{"key":"ref_33","first-page":"402","article-title":"Acute Vestibular Syndrome","volume":"27","author":"Steenerson","year":"2021","journal-title":"Continuum"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/B978-0-444-64189-2.00020-2","article-title":"Cerebellar stroke in adults and children","volume":"155","author":"Sarikaya","year":"2018","journal-title":"Handb. Clin. Neurol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"bcr2012008208","DOI":"10.1136\/bcr-2012-008208","article-title":"Gross cerebellar paraneoplastic neurological disorder in a patient with an occult breast cancer","volume":"2013","author":"Poudel","year":"2013","journal-title":"BMJ Case Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s12311-021-01363-3","article-title":"Novelties in Autoimmune and Paraneoplastic Cerebellar Ataxias: Twenty Years of Progresses","volume":"21","author":"Vogrig","year":"2022","journal-title":"Cerebellum"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e200015","DOI":"10.1212\/NXI.0000000000200015","article-title":"Immune and Genetic Signatures of Breast Carcinomas Triggering Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration","volume":"9","author":"Peter","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0959-4388(91)90018-3","article-title":"Learning-related synaptic plasticity: LTP and LTD","volume":"1","author":"Siegelbaum","year":"1991","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.brainres.2014.09.062","article-title":"Cerebellar learning mechanisms","volume":"1621","author":"Freeman","year":"2015","journal-title":"Brain Res."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Mitoma, H., Yamaguchi, K., Honnorat, J., and Manto, M. (2022). The Clinical Concept of LTDpathy: Is Dysregulated LTD Responsible for Prodromal Cerebellar Symptoms?. Brain Sci., 12.","DOI":"10.3390\/brainsci12030303"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/B978-0-444-63956-1.00006-0","article-title":"Physiology of the cerebellum","volume":"154","year":"2018","journal-title":"Handb. Clin. Neurol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41593-020-00754-9","article-title":"Diversity and dynamism in the cerebellum","volume":"24","author":"Lisberger","year":"2021","journal-title":"Nat. Neurosci."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Dade, M., Berzero, G., Izquierdo, C., Giry, M., Benazra, M., Delattre, J.-Y., Psimaras, D., and Alentorn, A. (2020). Neurological Syndromes Associated with Anti-GAD Antibodies. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21103701"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1007\/s13311-022-01188-w","article-title":"Stiff-person Syndrome and GAD Antibody-spectrum Disorders: GABAergic Neuronal Excitability, Immunopathogenesis and Update on Antibody Therapies","volume":"19","author":"Dalakas","year":"2022","journal-title":"Neurotherapeutics"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jns.2016.01.038","article-title":"Opsoclonus in a patient with increased titers of anti-GAD antibody provides proof for the conductance-based model of saccadic oscillations","volume":"362","author":"Shaikh","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.survophthal.2014.06.004","article-title":"Downbeat down south","volume":"60","author":"Chen","year":"2015","journal-title":"Surv. Ophthalmol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1212\/01.wnl.0000319725.22925.b4","article-title":"Stiff eyes in stiff-person syndrome","volume":"71","author":"Oskarsson","year":"2008","journal-title":"Neurology"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Bel\u00e9m, A.D., Vasconcelos, T.d.M.F., Paula, R.C.d.A.d., da Costa, F.B.S., Rodrigues, P.G.B., Pereira, I.d.S., Tavares, P.R.d.A., Galdino, G.S., Dias, D.A., and Santos, C.d.F. (2021). Stiff-Eye Syndrome\u2014Anti-GAD Ataxia Presenting with Isolated Ophthalmoplegia: A Case Report. Brain Sci., 11.","DOI":"10.3390\/brainsci11070932"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/B978-0-12-821751-1.00018-X","article-title":"Progressive external ophthalmoplegia","volume":"194","author":"Hirano","year":"2023","journal-title":"Handb. Clin. Neurol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s12311-018-0925-6","article-title":"Time Is Cerebellum","volume":"17","author":"Mitoma","year":"2018","journal-title":"Cerebellum"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s12311-019-01091-9","article-title":"Consensus Paper. Cerebellar Reserve: From Cerebellar Physiology to Cerebellar Disorders","volume":"19","author":"Mitoma","year":"2020","journal-title":"Cerebellum"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2183\/pjab.89.183","article-title":"Long-term depression and other synaptic plasticity in the cerebellum","volume":"89","author":"Hirano","year":"2013","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Gelfo, F., and Petrosini, L. (2022). Environmental Enrichment Enhances Cerebellar Compensation and Develops Cerebellar Reserve. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph19095697"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"fcac203","DOI":"10.1093\/braincomms\/fcac203","article-title":"Structural cerebellar reserve positively influences outcome after severe stroke","volume":"4","author":"Sadeghihassanabadi","year":"2022","journal-title":"Brain Commun."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neulet.2018.07.005","article-title":"The cerebellum and cognition","volume":"688","author":"Schmahmann","year":"2019","journal-title":"Neurosci. Lett."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1176\/jnp.12.2.193","article-title":"The role of the cerebellum in cognition and behavior: A selective review","volume":"12","author":"Rapoport","year":"2000","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"ref_57","first-page":"1","article-title":"Consensus Paper: Latent Autoimmune Cerebellar Ataxia (LACA)","volume":"29","author":"Manto","year":"2023","journal-title":"Cerebellum"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Shen, X.-N., Wu, K.-M., Huang, Y.-Y., Guo, Y., Huang, S.-Y., Zhang, Y.-R., Chen, S.-F., Wang, H.-F., Zhang, W., and Cheng, W. (2023). Systematic assessment of plasma biomarkers in spinocerebellar ataxia. Neurobiol. Dis., 181.","DOI":"10.1016\/j.nbd.2023.106112"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/ene.15648","article-title":"Anti-neurochondrin antibody as a biomarker in primary autoimmune cerebellar ataxia\u2014A case report and review of the literature","volume":"30","author":"Schwarzwald","year":"2023","journal-title":"Eur. J. Neurol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"105861","DOI":"10.1016\/j.parkreldis.2023.105861","article-title":"Immune-mediated ataxias: Guide to clinicians","volume":"20","author":"Meira","year":"2023","journal-title":"Park. Relat. Disord."}],"container-title":["Brain Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3425\/13\/12\/1626\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:28:55Z","timestamp":1760131735000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3425\/13\/12\/1626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,24]]},"references-count":60,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["brainsci13121626"],"URL":"https:\/\/doi.org\/10.3390\/brainsci13121626","relation":{},"ISSN":["2076-3425"],"issn-type":[{"value":"2076-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,24]]}}}